Measuring OS involves tracking the survival status of patients over a specified period. In clinical trials, this is typically done using Kaplan-Meier curves to estimate the survival function and median OS, which is the time at which 50% of the patients are still alive. The results are usually expressed in months or years, providing a clear timeline of patient outcomes.
